Zenas BioPharma, Inc. (ZBIO)
NASDAQ: ZBIO · Real-Time Price · USD
27.14
-0.12 (-0.44%)
Oct 12, 2026, 11:34 AM EDT - Market open
Zenas BioPharma Market Cap
Zenas BioPharma has a market cap or net worth of $1.77 billion as of October 12, 2026. It is the 7,324th most valuable company in the world and the 1,868th biggest in the United States. Its market cap has increased by 57.98% in one year.
Market Cap
1.77B
Enterprise Value
1.42B
1-Year Change
57.98%
Global Rank
Country Rank
#1,868 United States
Category
ChartMarket Cap Chart
Since the IPO on September 13, 2024, Zenas BioPharma's market cap has increased from $676.47M to $1.77B, an increase of 161.49%. That is a compound annual growth rate of 58.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 12, 2026 | 1.77B | -9.25% |
| Dec 31, 2025 | 1.95B | 469.46% |
| Dec 31, 2024 | 342.27M | -49.40% |
| Sep 13, 2024 | 676.47M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Generate Biomedicines | 1.84B |
| Intellia Therapeutics | 1.83B |
| Xencor | 1.83B |
| Zymeworks | 1.83B |
| Biohaven | 1.82B |
| Structure Therapeutics | 1.82B |
| Mesoblast | 1.81B |
| UroGen Pharma | 1.80B |